Thymic Carcinomas—A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Thoracic Oncology Année : 2022

Thymic Carcinomas—A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group

Anja Christiane Roden
  • Fonction : Auteur correspondant
  • PersonId : 1033353

Connectez-vous pour contacter l'auteur
Usman Ahmad
  • Fonction : Auteur
Giuseppe Cardillo
  • Fonction : Auteur
Deepali Jain
  • Fonction : Auteur
Edith Michelle Marom
  • Fonction : Auteur
Alexander H. Marx
  • Fonction : Auteur
André Luís Moreira
  • Fonction : Auteur
Andrew Gordon Nicholson
  • Fonction : Auteur
Arun Rajan
Annemarie Fernandes Shepherd
  • Fonction : Auteur
Charles B. Simone
Chad D. Strange
  • Fonction : Auteur
Małgorzata Szolkowska
  • Fonction : Auteur
Myelene T. Truong
  • Fonction : Auteur
Andreas Rimner

Résumé

Thymic carcinomas are rare malignancies that in general arise in the prevascular (anterior) mediastinum. These tumors are usually invasive, often present at advanced stages, and typically behave aggressively. Studies are hampered by the paucity of these tumors, the large variety of carcinoma subtypes, and the lack of unique morphologic and immunophenotypic features. Despite these challenges, advances in diagnostic imaging, surgical approaches, systemic therapies, and radiation therapy techniques have been made. The WHO classification of thymic epithelial tumors has been updated in 2021, and the eighth tumor nodal metastasis staging by the American Joint Committee on Cancer/Union for International Cancer Control included thymic carcinomas in 2017. Molecular alterations that provide more insight into the pathogenesis of these tumors and that potentially permit use of novel targeted therapies are increasingly being identified. New approaches to radiation therapy, chemotherapy, and immunotherapy are under evaluation. International societies, including the International Thymic Malignancy Interest Group, European Society of Thoracic Surgeons, and Japanese, Chinese, and Korean thymic associations, have been critical in organizing and conducting multi-institutional clinical studies. Herein, we review contemporary multidisciplinary perspectives in diagnosis and management of thymic carcinoma.

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-03772606 , version 1 (08-09-2022)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Anja Christiane Roden, Usman Ahmad, Giuseppe Cardillo, Nicolas Girard, Deepali Jain, et al.. Thymic Carcinomas—A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group. Journal of Thoracic Oncology, 2022, 17 (5), pp.637-650. ⟨10.1016/j.jtho.2022.01.021⟩. ⟨hal-03772606⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More